Market Cap 3.57B
Revenue (ttm) 11.27B
Net Income (ttm) -18.06M
EPS (ttm) N/A
PE Ratio 33.65
Forward PE 24.05
Profit Margin -0.16%
Debt to Equity Ratio 1.50
Volume 1,461,200
Avg Vol 2,835,418
Day's Range N/A - N/A
Shares Out 175.80M
Stochastic %K 6%
Beta 2.30
Analysts Strong Sell
Price Target $28.02

Company Profile

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. It operates through two segments, Pharmacy Solutions and Provider Services. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, a...

Industry: Health Information Services
Sector: Healthcare
Phone: 502 394 2100
Address:
805 North Whittington Parkway, Louisville, United States
DonCorleone77
DonCorleone77 Jul. 1 at 1:57 PM
$PNTG $EHAB $BTSG $ENH $ADUS Home health stocks under pressure following proposed rate cuts Shares of several home health services providers are under pressure on Tuesday after the Centers for Medicare and Medicaid Services proposed a 6.4% aggregate decrease in Medicare Home Health payments. The proposed cut to home nursing payment rates was worse than Wall Street seemed to be expecting. "The proposed CY 2026 updated rates include the proposed CY 2026 Home Health payment update of 2.4%; an estimated 3.7% decrease that reflects the net impact of the proposed permanent behavior adjustment, required by statute; an estimated 4.6% decrease that reflects the net impact of the proposed temporary adjustment; and an estimated 0.5% decrease that reflects the effects of a proposed update to the FDL ratio. CMS estimates that Medicare payments to home health agencies in CY 2026 would decrease in the aggregate by 6.4%, or $1.135 billion, compared to CY 2025, based on the proposed policies," CMS said. PRICE ACTION: Shares of Pennant Group (PNTG) are down over 7%, Enhabit (EHAB) is down almost 16%, and Brightspring Health Services (BTSG) is down about 3.5%. Also slipping lower this morning are Encompass Health (ENH), Addus Homecare (ADUS) and Amedisys (AMED).
0 · Reply
ZacksResearch
ZacksResearch Jun. 27 at 4:20 PM
$BTSG vs. $OPCH — which home infusion stock wins? BTSG posted 33% infusion growth and stronger EPS gains, putting it ahead of OPCH for now. Full breakdown here 👉 https://www.zacks.com/stock/news/2555130/btsg-vs-opch-which-home-infusion-stock-is-a-better-buy-now?cid=sm-stocktwits-2-2555130-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2555130_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 27 at 2:54 PM
$BTSG surging ahead — time to buy the dip? 🚀 🔹 33% growth in infusion & specialty pharmacy segment in Q1 2025 🔹 Raised 2025 guidance with revenue expected between $12B-$12.5B 🔹 Trading at an attractive forward P/S of 0.31x, relative to $OPCH’s 0.90x Discover why BrightSpring is a Zacks Rank #2 (Buy) while OPCH holds at #3 👇 https://www.zacks.com/commentary/2555130/btsg-vs-opch-which-home-infusion-stock-is-a-better-buy-now?cid=sm-stocktwits-2-2555130-body-315&ADID=SYND_STOCKTWITS_TWEET_2_2555130_BODY_315
0 · Reply
ZacksResearch
ZacksResearch Jun. 25 at 3:14 PM
$BTSG raises full-year outlook — is this growth momentum sustainable? 🚀 BrightSpring lifted 2025 revenue forecast to $12.0-$12.5 billion & EBITDA to $570-$585 million after a strong Q1, driven by a 33% revenue surge in Pharmacy Solutions and double-digit growth in hospice and home health care. Margins expected to expand with new efficiencies. 📈 Find out what could drive $BTSG higher 👉 https://www.zacks.com/commentary/2553698/btsg-raises-2025-financial-outlook-whats-backing-it?cid=sm-stocktwits-2-2553698-body-108&ADID=SYND_STOCKTWITS_TWEET_2_2553698_BODY_108
0 · Reply
ZacksResearch
ZacksResearch Jun. 25 at 1:13 PM
$BTSG just raised 2025 guidance — here’s what’s driving the upgrade 🔥 Pharmacy and Provider segments are showing strong gains, and margin initiatives are starting to pay off. Full breakdown of the outlook boost here 👉 https://www.zacks.com/stock/news/2553698/btsg-raises-2025-financial-outlook-whats-backing-it?cid=sm-stocktwits-2-2553698-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2553698_TEASER
0 · Reply
IN0V8
IN0V8 Jun. 23 at 3:55 PM
$BTSG Buy TD Cowen initiates coverage with buy rating TD Cowen initiates coverage with PT $37
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 1:26 PM
$BTSG delivers solid Q1 results and raises guidance — what's fueling the growth? 🚀 📈 Total revenues up 26% YoY, with Pharmacy Solutions and Provider Services leading the charge 💪 Adjusted EBITDA jumped 28%, driven by efficiency and volume leverage 📊 Full-year revenue guidance now set for 19.1-24.1% YoY growth Discover the full story behind BTSG's impressive performance 👉 https://www.zacks.com/commentary/2519657/can-brightsprings-q1-strength-carry-through-2025-headwinds?cid=sm-stocktwits-2-2519657-body&ADID=SYND_STOCKTWITS_TWEET_2_2519657_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 12:17 PM
$BTSG showed Q1 strength — but can it weather what's ahead? Pharmacy Solution and Provider Services delivered solid gains, but margin pressure looms as a 2025 headwind. Full breakdown of the setup here 👉 https://www.zacks.com/stock/news/2519657/can-brightsprings-q1-strength-carry-through-2025-headwinds?cid=sm-stocktwits-2-2519657-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2519657_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 3:47 PM
$BTSG surges 98.8% in a year, crushing the industry’s 18.9% decline! 🚀 Thanks to a booming Home Health Care segment with a 21% YoY sales increase and robust operational execution, BTSG is capitalizing on the shift toward home-based care. 📈 See what makes the investment case strong for BTSG 👉 https://www.zacks.com/commentary/2494410/brightsprings-home-health-arm-soars-whats-powering-growth?cid=sm-stocktwits-2-2494410-body&ADID=SYND_STOCKTWITS_TWEET_2_2494410_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 1:58 PM
$BTSG just hit an all-time high — but is the rally done or just getting started? Up 120% YTD, the move is backed by soaring quality ratings and strong Q1 results driving bullish sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2493149/brightspring-soars-to-all-time-high-on-quality-strength-still-a-buy?cid=sm-stocktwits-2-2493149-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2493149_TEASER
0 · Reply
Latest News on BTSG
BrightSpring Announces Secondary Offering of Common Stock

Jun 10, 2025, 4:16 PM EDT - 5 weeks ago

BrightSpring Announces Secondary Offering of Common Stock


HAVEN HOSPICE ACQUIRED BY BRIGHTSPRING HEALTH SERVICES

Sep 12, 2024, 11:17 AM EDT - 10 months ago

HAVEN HOSPICE ACQUIRED BY BRIGHTSPRING HEALTH SERVICES


DonCorleone77
DonCorleone77 Jul. 1 at 1:57 PM
$PNTG $EHAB $BTSG $ENH $ADUS Home health stocks under pressure following proposed rate cuts Shares of several home health services providers are under pressure on Tuesday after the Centers for Medicare and Medicaid Services proposed a 6.4% aggregate decrease in Medicare Home Health payments. The proposed cut to home nursing payment rates was worse than Wall Street seemed to be expecting. "The proposed CY 2026 updated rates include the proposed CY 2026 Home Health payment update of 2.4%; an estimated 3.7% decrease that reflects the net impact of the proposed permanent behavior adjustment, required by statute; an estimated 4.6% decrease that reflects the net impact of the proposed temporary adjustment; and an estimated 0.5% decrease that reflects the effects of a proposed update to the FDL ratio. CMS estimates that Medicare payments to home health agencies in CY 2026 would decrease in the aggregate by 6.4%, or $1.135 billion, compared to CY 2025, based on the proposed policies," CMS said. PRICE ACTION: Shares of Pennant Group (PNTG) are down over 7%, Enhabit (EHAB) is down almost 16%, and Brightspring Health Services (BTSG) is down about 3.5%. Also slipping lower this morning are Encompass Health (ENH), Addus Homecare (ADUS) and Amedisys (AMED).
0 · Reply
ZacksResearch
ZacksResearch Jun. 27 at 4:20 PM
$BTSG vs. $OPCH — which home infusion stock wins? BTSG posted 33% infusion growth and stronger EPS gains, putting it ahead of OPCH for now. Full breakdown here 👉 https://www.zacks.com/stock/news/2555130/btsg-vs-opch-which-home-infusion-stock-is-a-better-buy-now?cid=sm-stocktwits-2-2555130-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2555130_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 27 at 2:54 PM
$BTSG surging ahead — time to buy the dip? 🚀 🔹 33% growth in infusion & specialty pharmacy segment in Q1 2025 🔹 Raised 2025 guidance with revenue expected between $12B-$12.5B 🔹 Trading at an attractive forward P/S of 0.31x, relative to $OPCH’s 0.90x Discover why BrightSpring is a Zacks Rank #2 (Buy) while OPCH holds at #3 👇 https://www.zacks.com/commentary/2555130/btsg-vs-opch-which-home-infusion-stock-is-a-better-buy-now?cid=sm-stocktwits-2-2555130-body-315&ADID=SYND_STOCKTWITS_TWEET_2_2555130_BODY_315
0 · Reply
ZacksResearch
ZacksResearch Jun. 25 at 3:14 PM
$BTSG raises full-year outlook — is this growth momentum sustainable? 🚀 BrightSpring lifted 2025 revenue forecast to $12.0-$12.5 billion & EBITDA to $570-$585 million after a strong Q1, driven by a 33% revenue surge in Pharmacy Solutions and double-digit growth in hospice and home health care. Margins expected to expand with new efficiencies. 📈 Find out what could drive $BTSG higher 👉 https://www.zacks.com/commentary/2553698/btsg-raises-2025-financial-outlook-whats-backing-it?cid=sm-stocktwits-2-2553698-body-108&ADID=SYND_STOCKTWITS_TWEET_2_2553698_BODY_108
0 · Reply
ZacksResearch
ZacksResearch Jun. 25 at 1:13 PM
$BTSG just raised 2025 guidance — here’s what’s driving the upgrade 🔥 Pharmacy and Provider segments are showing strong gains, and margin initiatives are starting to pay off. Full breakdown of the outlook boost here 👉 https://www.zacks.com/stock/news/2553698/btsg-raises-2025-financial-outlook-whats-backing-it?cid=sm-stocktwits-2-2553698-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2553698_TEASER
0 · Reply
IN0V8
IN0V8 Jun. 23 at 3:55 PM
$BTSG Buy TD Cowen initiates coverage with buy rating TD Cowen initiates coverage with PT $37
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 1:26 PM
$BTSG delivers solid Q1 results and raises guidance — what's fueling the growth? 🚀 📈 Total revenues up 26% YoY, with Pharmacy Solutions and Provider Services leading the charge 💪 Adjusted EBITDA jumped 28%, driven by efficiency and volume leverage 📊 Full-year revenue guidance now set for 19.1-24.1% YoY growth Discover the full story behind BTSG's impressive performance 👉 https://www.zacks.com/commentary/2519657/can-brightsprings-q1-strength-carry-through-2025-headwinds?cid=sm-stocktwits-2-2519657-body&ADID=SYND_STOCKTWITS_TWEET_2_2519657_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 20 at 12:17 PM
$BTSG showed Q1 strength — but can it weather what's ahead? Pharmacy Solution and Provider Services delivered solid gains, but margin pressure looms as a 2025 headwind. Full breakdown of the setup here 👉 https://www.zacks.com/stock/news/2519657/can-brightsprings-q1-strength-carry-through-2025-headwinds?cid=sm-stocktwits-2-2519657-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2519657_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 3:47 PM
$BTSG surges 98.8% in a year, crushing the industry’s 18.9% decline! 🚀 Thanks to a booming Home Health Care segment with a 21% YoY sales increase and robust operational execution, BTSG is capitalizing on the shift toward home-based care. 📈 See what makes the investment case strong for BTSG 👉 https://www.zacks.com/commentary/2494410/brightsprings-home-health-arm-soars-whats-powering-growth?cid=sm-stocktwits-2-2494410-body&ADID=SYND_STOCKTWITS_TWEET_2_2494410_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 1:58 PM
$BTSG just hit an all-time high — but is the rally done or just getting started? Up 120% YTD, the move is backed by soaring quality ratings and strong Q1 results driving bullish sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2493149/brightspring-soars-to-all-time-high-on-quality-strength-still-a-buy?cid=sm-stocktwits-2-2493149-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2493149_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 1:20 PM
$BTSG just delivered a 21% Q1 sales pop — here’s what’s driving it 📈 Home Health Care segment surged on Medicare Advantage tailwinds and strong patient satisfaction — a powerful combo for sustained growth. What’s next for BTSG? Full breakdown here 👉 https://www.zacks.com/stock/news/2494410/brightsprings-home-health-arm-soars-whats-powering-growth?cid=sm-stocktwits-2-2494410-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494410_TEASER
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 11 at 12:51 PM
$BTSG (-2.0% pre) BrightSpring Announces Pricing of Secondary Offering of Common Stock https://ooc.bz/l/67673
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 12:49 PM
$BTSG soaring 120% over the past year—what's fueling the rocket? 🚀 BrightSpring crushed Q1 2025 with 14% revenue growth, a 111% EPS leap, and a 19% rise in adjusted EBITDA, blowing past Zacks Consensus Estimates. The stock is still undervalued with a forward P/S ratio of 0.32, below peers like Amedisys and OPCH. Discover why BTSG might have more room to run 👉 https://www.zacks.com/commentary/2493149/brightspring-soars-to-all-time-high-on-quality-strength-still-a-buy?cid=sm-stocktwits-2-2493149-body&ADID=SYND_STOCKTWITS_TWEET_2_2493149_BODY
0 · Reply
DonCorleone77
DonCorleone77 Jun. 11 at 10:15 AM
$BTSG BrightSpring Health 14M share Spot Secondary priced at $21.75 The deal range was $21.50-$22.24. Goldman Sachs and BofA acted as joint book running managers for the offering.
0 · Reply
God_Damnit
God_Damnit Jun. 11 at 3:14 AM
Thou shall buy $SSY GDDMNIT! I said, let it rain And it shall rain money all upon you $BY offering $KRT offering $BTSG offering SSY PROVIDES YOU WITH THE OFFERING All You have to do is buy and wait for the upcoming catalyst news
0 · Reply
Chomo
Chomo Jun. 11 at 1:06 AM
$BTSG Someone knew and made that selling today...
1 · Reply
DonCorleone77
DonCorleone77 Jun. 11 at 12:14 AM
$GTLB $PLAY $GME $BTSG $SSTK Feel free to follow me for pre-market and after-hours movers every day. AFTER-HOURS MOVERS: Currently Higher After Earnings: -- Dave & Buster's (PLAY) up 4.8% -- Stitch Fix (SFIX) up 7.5% Currently Also Higher: -- Shutterstock (SSTK) up 6.1% as stockholders approve merger agreement with Getty Images -- Vitesse Energy (VTS) up 1.8% after insider buy -- Evolus (EOLS) up 2.8% after insider buy Currently Lower After Earnings: -- GitLab (GTLB) down 12.6% -- MIND Technology (MIND) down 9.0% -- GameStop (GME) down 3.6% Currently Also Lower: -- American Superconductor (AMSC) down 12.0% after equity offering -- Nucor (NUE) down 4.6%, Cleveland-Cliffs (CLF) down 4.2% as Bloomberg reports that U.S. and Mexico are near deal to remove 50% steel tariff -- BrightSpring Health (BTSG) down 3.3% 14M share Spot Secondary
0 · Reply
DonCorleone77
DonCorleone77 Jun. 11 at 12:02 AM
$BTSG BrightSpring Health 14M share Spot Secondary; price range $21.50-$22.24 Goldman Sachs and BofA are acting as joint book running managers for the offering.
0 · Reply
vvvvvvrebel89130
vvvvvvrebel89130 Jun. 10 at 11:12 PM
$BTSG No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering.
0 · Reply
vvvvvvrebel89130
vvvvvvrebel89130 Jun. 10 at 11:11 PM
$BTSG u do know this is positive; prepping to sell into spike
0 · Reply
pyshin123
pyshin123 Jun. 10 at 9:16 PM
$BTSG goes to show that insider trading is alive and well!!!
0 · Reply
Fundamentals_1st
Fundamentals_1st Jun. 10 at 8:32 PM
$BTSG I guess we know why it was down big today.
0 · Reply